Jérémy MALATERRE

Entrepreneurship in the service of the climate emergency! We identify, fund, and launch 100 companies designed and structured from start to finish to combat greenhouse gases. Our mission: > identify high-impact innovations; > recruit experienced entrepreneurs to transform these innovations into companies with solid business models; > inject financial resources to maximize and accelerate deployment. All innovations are made available as open source. Every euro raised is used to combat climate change. Any individual or organization can join the effort starting at €1 on our website (in just a few minutes) and take concrete action, on a global scale, against climate change. Everything is detailed (and you can contact us) at team-planet.com

Entrepreneurship in the service of the climate emergency! We identify, fund, and launch 100 companies designed and structured from start to finish to combat greenhouse gases. Our mission: > identify high-impact innovations; > recruit experienced entrepreneurs to transform these innovations into companies with solid business models; > inject financial resources to maximize and accelerate deployment. All innovations are made available as open source. Every euro raised is used to combat climate change. Any individual or organization can join the effort starting at €1 on our website (in just a few minutes) and take concrete action, on a global scale, against climate change. Everything is detailed (and you can contact us) at team-planet.com

Sandoz is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients. More than 20,000 people of 100 nationalities work together to ensure 900 million patient treatments are provided by Sandoz annually, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer. Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in 2006. In 2024, Sandoz recorded net sales of USD 10.4 billion. Read our community engagement guidelines: http://bit.ly/4ofoggc

Avec un marché du médicament qui représente plus de 20 milliards de dollars, l’accès à des produits abordables et de qualité reste un défi majeur pour l’Afrique. CFAO Healthcare, renforce l’offre de santé sur le continent en produisant et distribuant des produits et services pharmaceutiques et médicaux.